Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Distal Lateral Subungual Onychomycosis of the Toenail
Conditions
Interventions
VT-1161
Placebo
Locations
33
United States
The Kirklin Clinic of UAB Hospital
Birmingham, Alabama, United States
Radiant Research
Tucson, Arizona, United States
Dermatology Specialists, Inc
Oceanside, California, United States
Therapeutics Clinical Research
San Diego, California, United States
Center For Clinical Research
San Francisco, California, United States
Radiant Research
Santa Rosa, California, United States
Start Date
February 17, 2015
Primary Completion Date
October 18, 2016
Completion Date
July 7, 2017
Last Updated
November 4, 2020
NCT06689852
NCT00233493
NCT06175013
NCT02022215
NCT06254027
NCT05809297
Lead Sponsor
Viamet
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions